ClinicalTrials.gg
Not yet recruitingNCT07726498STRIDEUpdated Jul 24, 2026

STRIDE: Strength of The Calf Muscles and Their Role In Declining Effectiveness of Movement With Aging

An observational study in Sarcopenia, Aging and Muscle Weakness or Atrophy, sponsored by University of Leicester. Not yet recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-24.

Sponsored by University of Leicester · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
200
Ages
18 Years and older
Sex
All
01

Study summary

The calf muscles (plantarflexors) are the most important muscles for walking, running and daily activities. Weakness of these muscles through aging and disease significantly impact a person's ability to walk and complete daily activities. By assessing calf strength, it is possible to identify people at risk of falls, and a condition called sarcopenia (which means loss of muscle mass, strength and function). Unfortunately, most of the studies that have examined this have used specialist equipment unavailable to hospital staff. Our study aims to use commercially available equipment to explore the relationship between plantarflexor muscle strength and physical performance in adults living with or without sarcopenia, including those at risk of it. The study will determine if stronger/weaker calf muscles associated with sarcopenia influence the ability to walk and do things more easily. We will complete strength tests of the calf, thigh and hand, assess walking using a special camera system, use an ultrasound scan to look at the Achilles tendon, use a scan to look at how stiff your calf muscles are, assess your body composition, complete a physical performance test and some questionnaires. Each participant will complete the measures during one clinic visit

Read the detailed description

This study aims to assess the relationship between plantarflexor (calf muscles) muscle strength and physical performance between people with and without sarcopenia. The measurements include Isometric plantarflexor strength testing, Theia markerless motion capture system, Ultrasound Tissue Characterization Imaging, Elastography, Grip strength, Isometric Knee Extension Strength Test, Bioelectrical Impedance analysis, Short Physical Performance Battery. In addition the SARC-F, Falls Efficacy Scale- International (FES-I), EuroQol- 5 Dimension (EQ-5D-5L) and Short-Form-12-health-survey (SF-12) questionnaires will be completed.

02

Conditions studied

  • Sarcopenia
  • Aging
  • Muscle Weakness or Atrophy
  • Frailty

Keywords

  • Plantarflexors
  • Sarcopenia
  • Aging
  • Weakness
  • Multi-morbidity
03

In context

Sarcopenia

1,329 studies on the registry are indexed under Sarcopenia; 420 are open to participants now.

This study's planned enrollment of 200 is above the median of 120 across 455 observational studies indexed under Sarcopenia.

Browse Sarcopenia studies →

Lead sponsor

University of Leicester is the lead sponsor of 170 studies on the registry; 51 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population is individuals over the age of 18 years, who may or may not have sarcopenia.

Individuals will be determined as either sarcopenic or non-sarcopenic by completing the outcome measures (SARC-F questionnaire, Grip strength, BIA and SPPB) and using the cut-off values as recommended by the European Working Group on Sarcopenia in Older People 2 consensus.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participant is able and willing to provide to participate in the study
  • Aged 18 years or over
  • Ambulatory status: able to walk independently with or without aids
  • Able to attend clinic

Exclusion criteria

Exclusion Criteria:

  • Participant is unwilling or unable to give .
  • Palliative/ end of life
  • Moderate to severe communication difficulties/ cognitive function
  • Immobile
  • Lower limb surgery within the last 6 months
  • Recent lower limb fracture
  • Unstable cardiopulmonary conditions
  • Severe impairments of vision or vestibular system
  • Lower limb injection within the last 6 months
  • No restriction on language
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • Sarcopenic

    Other: No intervention (observational study)

  • Non Sarcopenic

    Other: No intervention (observational study)

Interventions

  • OtherNo intervention (observational study)

    No intervention (observational study)

06

What researchers measure

Primary outcomes

  1. Isometric plantarflexor strength testing

    Isometric plantarflexor strength will be tested using the Fysiometer C-station

    Time frame: Baseline

Secondary outcomes

  1. Theia markerless motion capture system

    Gait will be assessed using Theia 3D (Theia Markerless Inc., Kingston, ON, Canada). Theia 3D is a commercial markerless motion capture system which uses multiple cameras to capture video footage of physical performance, tracking 124 keypoints producing 3D models. Calibration it completed prior to recording. Data is processed in Theia 3D and analysed in Visual 3D software. Measures such as gait speed and pattern, forces, joint angles, stride length and cadence will be collected.

    Time frame: Baseline

  2. Ultrasound Tissue Characterization Imaging

    Imaging of the Achilles Tendon to identify structural changes to the Achilles tendon.

    Time frame: Baseline

  3. Elastography

    Imaging of the Plantarflexors and Achilles Tendon to understand muscle stiffness and tissue mechanical properties

    Time frame: Baseline

  4. Grip strength

    A Jamar hand dynamometer will be used, measuring grip strength in kilograms

    Time frame: Baseline

  5. Isometric Knee Extension Strength Test

    Isometric Knee Extension strength will be measured using Kinvent K-Pull incline dynamometer

    Time frame: Baseline

  6. Bioelectrical Impedance analysis

    Bioelectrical impedance analysis (BIA) will be used to estimate body composition and Skeletal Muscle Mass.

    Time frame: Baseline

  7. Short Physical Performance Battery

    It consists of three key components: balance tests, gait speed and chair stand test. Participants who are unable to complete a component score 0, whereas a score of 4 indicates highest performance of that component. Each component is scored out of 4 points with a maximum combined score of 12 points.

    Time frame: Baseline

  8. SARC-F questionnaire

    The questionnaire contains 5 questions/components, covering strength, assistance with walking, rise from a chair, climb stairs and falls. Each component is scored ranging from 0 to 2 points, with a minimum combined score of 0 and a maximal combined score of 10. A score equal to or greater than 4 is predictive of sarcopenia and poor outcomes.

    Time frame: Baseline

  9. Falls Efficacy Scale- International (FES-I)

    The questionnaire contains sixteen questions/items. Each question/item is scored on a four-point Likert scale (1- not at all concerned; 2- somewhat concerned; 3- fairly concerned; 4- very concerned). The total score ranges from 16-64.

    Time frame: Baseline

  10. EuroQol- 5 Dimension (EQ-5D-5L)

    It consists of five dimensions (mobility, self-care, usual activities, pain/discomfort, anxiety/depression) and a visual analogue scale where individuals rate their overall health on a scale of 0-100.

    Time frame: Baseline

  11. Short-Form-12-health-survey (SF-12)

    It measures eight domains, covering physical functioning, role physical, bodily pain, general health perception, energy/vitality, social functioning, role emotional and mental health. Two summary scores are reported (Physical Component Summary and Mental Component Summary).

    Time frame: Baseline

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07726498
Collaborators
University Hospitals, Leicester
Responsible party
Sponsor
First posted
Jul 24, 2026
Start date
Aug 2026 (estimated)
Primary completion
Feb 29, 2028 (estimated)
Completion
Feb 29, 2028 (estimated)
Last update
Jul 24, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion